VATENYSEFabricated Structural Metal ProductsUS GAAP · USD

INNOVATE Corp.

INNOVATE Corp. is a U.S.-based holding company that owns and manages a portfolio of operating businesses, with reported segments spanning infrastructure, broadcasting/spectrum, and life sciences. The company is actively reshaping its portfolio through acquisitions, divestitures, refinancing, and strategic alternatives while using subsidiary cash flows to support its capital structure.

Ask about the company
Revenue1,246m USD
+12.5 %y/y
Operating profit (EBIT)28.7m USD
−28.3 %y/y
EBIT margin2.3%
−1.3 ppy/y
Net income-60.6m USD
−75.1 %y/y

Fiscal year 2025 · change from previous year

Development 2020–2025

-50005001,0001,5002,000m USD2020: 717 m USD2020: EBIT -28 m USD20202021: 1,205 m USD2021: EBIT -11 m USD20212022: 1,637 m USD2022: EBIT 13 m USD20222023: 1,423 m USD2023: EBIT 27 m USD20232024: 1,107 m USD2024: EBIT 40 m USD20242025: 1,246 m USD2025: EBIT 29 m USD20251,24629
RevenueOperating profit (EBIT)

Business

Share of revenue
Infrastructure70 %

Structural steel fabrication, erection, and related project execution for industrial and commercial customers.

Spectrum / Broadcasting20 %

Broadcasting and direct-response advertising operations that monetize network and media inventory.

Life Sciences5 %

Investment and development-stage activities tied to healthcare and biotechnology portfolio companies.

Corporate and Other5 %

Holding-company activities, financing costs, eliminations, and strategic transaction management.

Customers

The company serves project-based infrastructure customers that need fabricated structural metal products and execution capacity for large jobs. Its Spectrum segment sells advertising and network access tied to direct-response media demand, while the Life Sciences segment is oriented toward portfolio companies and healthcare/biotech development opportunities. Customer demand is therefore split between construction/end-market project owners, advertisers/media buyers, and investment counterparties.

Infrastructure project customers

Buy structural metal fabrication and project execution for fixed-price or cost-reimbursable jobs; they value schedule, cost control, and bonding capacity.

Direct-response advertisers

Buy Spectrum advertising inventory to reach measurable-response audiences; demand depends on campaign economics and market conditions.

Healthcare and biotech portfolio companies

Receive capital and development support through the Life Sciences segment to advance products and treatments.

Financial counterparties

Include lenders, noteholders, and bond providers that influence liquidity, covenant compliance, and strategic flexibility.

Strategy

INNOVATE is pursuing an active portfolio strategy that includes growing, acquiring, winding down, or selling operating businesses depending on value creation and capital structure needs. Management also highlighted debt refinancing and subsidiary-level financing as priorities to support operations while it evaluates strategic alternatives. The stated direction suggests a focus on monetizing assets, improving liquidity, and preserving optionality across the portfolio.

Portfolio rationalization and strategic alternativesMedium term

The company is actively considering sales, wind-downs, and acquisitions to reshape the business mix and unlock value.

Debt refinancing and liquidity supportShort term

Refinancing helps fund operations and reduces near-term financing pressure across the parent and subsidiaries.

Capital structure repair through asset monetizationMedium term

Strategic transactions are intended to generate proceeds that can be used to address leverage and covenant constraints.

Geography

The available excerpts do not disclose a country-by-country revenue split, so the business profile should be viewed as U.S.-centered based on the company’s domicile and reporting. Operational exposure is driven more by end-market and segment mix than by international geography, with infrastructure project execution, U.S. media demand, and U.S.-based financing terms all affecting performance. Because the company relies on debt markets and project activity, domestic interest rates, inflation, and capital market conditions are especially important.

Risks

The company faces elevated balance-sheet and covenant risk because its debt agreements and preferred stock terms restrict operating flexibility and can trigger defaults if tests are missed. Business performance is also exposed to project timing, customer churn, advertising market weakness, litigation, and the ability of subsidiaries to upstream cash. These risks are amplified by inflation, interest rates, subcontractor performance, and the need to refinance or raise capital in uncertain markets.

Sorted by severity
LowMediumHighLowMediumHighImpact →Likelihood →Debt covenant breach and cross-default risk1Liquidity and refinancing risk2Claims, litigation, and change-order disputes4
Impact is the risk’s severity and likelihood how probable it is over the next few years, both assessed from the company’s reports. Numbers match the list.
  1. Debt covenant breach and cross-default riskImpact: HighLikelihood: High

    Multiple note indentures and preferred stock terms impose financial and operating restrictions; failure can accelerate debt.

    Exposure: Parent and subsidiary financing agreements

  2. Liquidity and refinancing riskImpact: HighLikelihood: High

    The company depends on refinancing and capital access to fund operations and support subsidiaries.

    Exposure2026 and 2027 notesRevolving line of credit
  3. Project execution and subcontractor riskImpact: High

    Infrastructure margins can be hurt by labor productivity issues, weather, cost overruns, and subcontractor performance.

    Exposure: Fixed-price and cost-reimbursable contracts

  4. Claims, litigation, and change-order disputesImpact: MediumLikelihood: Low

    Unfavorable outcomes or delayed settlements can reduce cash flow and increase operating volatility.

    Exposure: Infrastructure contracts and corporate matters

  5. Customer churn and advertising market weaknessImpact: Medium

    Spectrum revenue declined due to customer terminations and a downturn in direct-response advertising.

    Exposure: Broadcasting segment

Accounting

Judgemental items
Revenue and margin estimates on long-term contracts

Infrastructure results depend on management estimates for contract performance, cost savings, and change orders.

Impact: Can shift revenue, gross margin, and operating income between periods

Claims and unapproved change orders

Recognition depends on negotiation outcomes and collectability, which are inherently uncertain.

Impact: Affects revenue timing and cash conversion

Debt and preferred stock accounting

Multiple notes, revolvers, and preferred instruments create complex interest, covenant, and classification issues.

Impact: Affects interest expense, liquidity disclosures, and default risk

Strategic transaction and exit costs

Portfolio reshaping can generate realignment, acquisition/disposition, and wind-down charges.

Impact: Can materially affect comparability of reported earnings

Similar listed companies

Publicly listed companies with a comparable business focus.

Innventure, Inc.

INVLW · Blank Checks

Innovative Eyewear Inc

LUCYW · Ophthalmic Goods

InnovAge Holding Corp.

INNV · Services-Health Services

INVE Technologies, Inc.

INVE · Computer Peripheral Equipment, NEC

Innovex International, Inc.

INVX · Oil & Gas Field Machinery & Equipment

INVO Fertility, Inc.

IVF · Surgical & Medical Instruments & Apparatus

Last updated: 24/09/2026

INNOVATE Corp. (VATE) Revenue, Earnings & Financials 2025 – Clarifo